APO RESEARCH · REPORT
Laboratory-developed Testing
Twenty-five years ago, the Food and Drug Administration (FDA) asserted in a draft document that "home brew" tests-now commonly referred to as laboratory-developed tests (LDTs)-are subject to the same regulatory oversight as other in vitro diagnostics (IVDs)4. In 2010, the FDA began work on developing a proposed framework for future LDT oversight. Released in 2014, the draft guidance sparked an intense debate over potential LDT regulation. While the proposed guidance has not been implemented, many questions regarding LDT oversight remain unresolved.
Product & engineering
Understand the product.
Twenty-five years ago, the Food and Drug Administration (FDA) asserted in a draft document that "home brew" tests-now commonly referred to as laboratory-developed tests (LDTs)-are subject to the same regulatory oversight as other in vitro diagnostics (IVDs)4. In 2010, the FDA began work on developing a proposed framework for future LDT oversight. Released in 2014, the draft guidance sparked an intense debate over potential LDT regulation. While the proposed guidance has not been implemented, many questions regarding LDT oversight remain unresolved.
A laboratory developed test (LDT) is a type of in vitro diagnostic test that is designed, manufactured and used within a single laboratory.
LDTs can be used to measure or detect a wide variety of analytes (substances such as proteins, chemical compounds like glucose or cholesterol, or DNA), in a sample taken from a human body. Some LDTs are relatively simple tests that measure single analytes, such as a test that measures the level of sodium. Other LDTs are complex and may measure or detect one or more analytes. For example, some tests can detect many DNA variations from a single blood sample, which can be used to help diagnose a genetic disease. Various levels of chemicals can be measured to help diagnose a patient’s state of health, such as levels of cholesterol or sodium.
While the uses of an LDT are often the same as the uses of FDA-cleared or approved in vitro diagnostic tests, some labs may choose to offer their own test. For example, a hospital lab may run its own vitamin D assay, even though there is an FDA-cleared test for vitamin D currently on the market.
Selected research
Industry Research
Laboratory-developed Testing Industry Research Report 2026
Market perspective
Twenty-five years ago, the Food and Drug Administration (FDA) asserted in a draft document that "home brew" tests-now commonly referred to as laboratory-developed tests (LDTs)-are subject to the same regulatory oversight as other in vitro diagnostics (IVDs)4. In 2010, the FDA began work on developing a proposed framework for future LDT oversight. Released in 2014, the draft guidance sparked an intense debate over potential LDT regulation. While the proposed guidance has not been implemented, many questions regarding LDT oversight remain unresolved.
A laboratory developed test (LDT) is a type of in vitro diagnostic test that is designed, manufactured and used within a single laboratory.
LDTs can be used to measure or detect a wide variety of analytes (substances such as proteins, chemical compounds like glucose or cholesterol, or DNA), in a sample taken from a human body. Some LDTs are relatively simple tests that measure single analytes, such as a test that measures the level of sodium. Other LDTs are complex and may measure or detect one or more analytes. For example, some tests can detect many DNA variations from a single blood sample, which can be used to help diagnose a genetic disease. Various levels of chemicals can be measured to help diagnose a patient’s state of health, such as levels of cholesterol or sodium.
Read the full market overview
While the uses of an LDT are often the same as the uses of FDA-cleared or approved in vitro diagnostic tests, some labs may choose to offer their own test. For example, a hospital lab may run its own vitamin D assay, even though there is an FDA-cleared test for vitamin D currently on the market.
The leading players in laboratory-developed testing include Quest Diagnostics, Roche, Illumina, Qiagen, and Eurofins, with the top three accounting for approximately 15% of the market.
North America is the largest market with more than 65% of the market, followed by Europe with about 15%.
Report Scope
This report quantifies the global Laboratory-developed Testing market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Laboratory-developed Testing.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Laboratory-developed Testing Market by Company
Adaptive Biotechnologies Corporation
Quest Diagnostics
Roche
Illumina
Qiagen
Eurofins
Guardant Health
Biotheranostics
Adaptive Biotechnologies
Rosetta Genomics
Biodesix
Helix
Laboratory-developed Testing Segment by Type
Commercial Service
R&D
Laboratory-developed Testing Segment by Application
Genetic Testing
Oncology
Infectious Disease
Others
Laboratory-developed Testing Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Laboratory-developed Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Laboratory-developed Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Laboratory-developed Testing.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Laboratory-developed Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Commercial Service
- R&D
Applications
- Genetic Testing
- Oncology
- Infectious Disease
- Others
Companies covered
- Adaptive Biotechnologies Corporation
- Quest Diagnostics
- Roche
- Illumina
- Qiagen
- Eurofins
- Guardant Health
- Biotheranostics
- Adaptive Biotechnologies
- Rosetta Genomics
- Biodesix
- Helix
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Laboratory-developed Testing by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Commercial Service
- 2.2.3 R&D
- 2.3 Laboratory-developed Testing by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Genetic Testing
- 2.3.3 Oncology
- 2.3.4 Infectious Disease
- 2.3.5 Others
- 2.4 Assumptions and Limitations
3 Laboratory-developed Testing Breakdown Data by Type
- 3.1 Global Laboratory-developed Testing Historic Market Size by Type (2021-2026)
- 3.2 Global Laboratory-developed Testing Forecasted Market Size by Type (2027-2032)
4 Laboratory-developed Testing Breakdown Data by Application
- 4.1 Global Laboratory-developed Testing Historic Market Size by Application (2021-2026)
- 4.2 Global Laboratory-developed Testing Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Laboratory-developed Testing Market Perspective (2021-2032)
- 5.2 Global Laboratory-developed Testing Growth Trends by Region
- 5.2.1 Global Laboratory-developed Testing Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Laboratory-developed Testing Historic Market Size by Region (2021-2026)
- 5.2.3 Laboratory-developed Testing Forecasted Market Size by Region (2027-2032)
- 5.3 Laboratory-developed Testing Market Dynamics
- 5.3.1 Laboratory-developed Testing Industry Trends
- 5.3.2 Laboratory-developed Testing Market Drivers
- 5.3.3 Laboratory-developed Testing Market Challenges
- 5.3.4 Laboratory-developed Testing Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Laboratory-developed Testing Players by Revenue
- 6.1.1 Global Top Laboratory-developed Testing Players by Revenue (2021-2026)
- 6.1.2 Global Laboratory-developed Testing Revenue Market Share by Players (2021-2026)
- 6.2 Global Laboratory-developed Testing Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Laboratory-developed Testing Head Office and Area Served
- 6.4 Global Laboratory-developed Testing Players, Product Type & Application
- 6.5 Global Laboratory-developed Testing Manufacturers Established Date
- 6.6 Global Laboratory-developed Testing Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Laboratory-developed Testing Market Size (2021-2032)
- 7.2 North America Laboratory-developed Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Laboratory-developed Testing Market Size by Country (2021-2026)
- 7.4 North America Laboratory-developed Testing Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Laboratory-developed Testing Market Size (2021-2032)
- 8.2 Europe Laboratory-developed Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Laboratory-developed Testing Market Size by Country (2021-2026)
- 8.4 Europe Laboratory-developed Testing Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Laboratory-developed Testing Market Size (2021-2032)
- 9.2 Asia-Pacific Laboratory-developed Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Laboratory-developed Testing Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Laboratory-developed Testing Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Laboratory-developed Testing Market Size (2021-2032)
- 10.2 South America Laboratory-developed Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Laboratory-developed Testing Market Size by Country (2021-2026)
- 10.4 South America Laboratory-developed Testing Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Laboratory-developed Testing Market Size (2021-2032)
- 11.2 Middle East & Africa Laboratory-developed Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Laboratory-developed Testing Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Laboratory-developed Testing Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Adaptive Biotechnologies Corporation
- 12.1.1 Adaptive Biotechnologies Corporation Company Information
- 12.1.2 Adaptive Biotechnologies Corporation Business Overview
- 12.1.3 Adaptive Biotechnologies Corporation Revenue in Laboratory-developed Testing Business (2021-2026)
- 12.1.4 Adaptive Biotechnologies Corporation Laboratory-developed Testing Product Portfolio
- 12.1.5 Adaptive Biotechnologies Corporation Recent Developments
- 12.2 Quest Diagnostics
- 12.2.1 Quest Diagnostics Company Information
- 12.2.2 Quest Diagnostics Business Overview
- 12.2.3 Quest Diagnostics Revenue in Laboratory-developed Testing Business (2021-2026)
- 12.2.4 Quest Diagnostics Laboratory-developed Testing Product Portfolio
- 12.2.5 Quest Diagnostics Recent Developments
- 12.3 Roche
- 12.3.1 Roche Company Information
- 12.3.2 Roche Business Overview
- 12.3.3 Roche Revenue in Laboratory-developed Testing Business (2021-2026)
- 12.3.4 Roche Laboratory-developed Testing Product Portfolio
- 12.3.5 Roche Recent Developments
- 12.4 Illumina
- 12.4.1 Illumina Company Information
- 12.4.2 Illumina Business Overview
- 12.4.3 Illumina Revenue in Laboratory-developed Testing Business (2021-2026)
- 12.4.4 Illumina Laboratory-developed Testing Product Portfolio
- 12.4.5 Illumina Recent Developments
- 12.5 Qiagen
- 12.5.1 Qiagen Company Information
- 12.5.2 Qiagen Business Overview
- 12.5.3 Qiagen Revenue in Laboratory-developed Testing Business (2021-2026)
- 12.5.4 Qiagen Laboratory-developed Testing Product Portfolio
- 12.5.5 Qiagen Recent Developments
- 12.6 Eurofins
- 12.6.1 Eurofins Company Information
- 12.6.2 Eurofins Business Overview
- 12.6.3 Eurofins Revenue in Laboratory-developed Testing Business (2021-2026)
- 12.6.4 Eurofins Laboratory-developed Testing Product Portfolio
- 12.6.5 Eurofins Recent Developments
- 12.7 Guardant Health
- 12.7.1 Guardant Health Company Information
- 12.7.2 Guardant Health Business Overview
- 12.7.3 Guardant Health Revenue in Laboratory-developed Testing Business (2021-2026)
- 12.7.4 Guardant Health Laboratory-developed Testing Product Portfolio
- 12.7.5 Guardant Health Recent Developments
- 12.8 Biotheranostics
- 12.8.1 Biotheranostics Company Information
- 12.8.2 Biotheranostics Business Overview
- 12.8.3 Biotheranostics Revenue in Laboratory-developed Testing Business (2021-2026)
- 12.8.4 Biotheranostics Laboratory-developed Testing Product Portfolio
- 12.8.5 Biotheranostics Recent Developments
- 12.9 Adaptive Biotechnologies
- 12.9.1 Adaptive Biotechnologies Company Information
- 12.9.2 Adaptive Biotechnologies Business Overview
- 12.9.3 Adaptive Biotechnologies Revenue in Laboratory-developed Testing Business (2021-2026)
- 12.9.4 Adaptive Biotechnologies Laboratory-developed Testing Product Portfolio
- 12.9.5 Adaptive Biotechnologies Recent Developments
- 12.10 Rosetta Genomics
- 12.10.1 Rosetta Genomics Company Information
- 12.10.2 Rosetta Genomics Business Overview
- 12.10.3 Rosetta Genomics Revenue in Laboratory-developed Testing Business (2021-2026)
- 12.10.4 Rosetta Genomics Laboratory-developed Testing Product Portfolio
- 12.10.5 Rosetta Genomics Recent Developments
- 12.11 Biodesix
- 12.11.1 Biodesix Company Information
- 12.11.2 Biodesix Business Overview
- 12.11.3 Biodesix Revenue in Laboratory-developed Testing Business (2021-2026)
- 12.11.4 Biodesix Laboratory-developed Testing Product Portfolio
- 12.11.5 Biodesix Recent Developments
- 12.12 Helix
- 12.12.1 Helix Company Information
- 12.12.2 Helix Business Overview
- 12.12.3 Helix Revenue in Laboratory-developed Testing Business (2021-2026)
- 12.12.4 Helix Laboratory-developed Testing Product Portfolio
- 12.12.5 Helix Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst